Skip to main content

GLP-1 RA Use Linked to Retained Gastric Contents During Endoscopies

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 4, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Oct. 4, 2024 -- Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with the risk for retained gastric contents and inadequate bowel preparation during endoscopic procedures, according to a research letter published online Oct. 1 in JAMA Network Open.

Jason Nasser, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues examined the potential associations between GLP-1 RA use and risks for gastric food retention and periprocedural aspiration during esophagogastroduodenoscopies (EGDs), when EGD was combined with colonoscopy, and in colonoscopy alone in a retrospective, single-center cross-sectional study. Individuals taking GLP-1 RAs at the time of endoscopy were matched for age, body mass index subgroup, sex, and procedure with individuals in a control group (70 and 139 individuals, respectively).

Overall, 33 percent of the cohort underwent EGD, 33 percent underwent colonoscopy, and 34 percent underwent both. The researchers found that four of 23 individuals (17.4 percent) in the GLP-1 RA group undergoing EGD alone and none of 46 in the control group had food retention (odds ratio, 21.5). In combined EGD-colonoscopies, there was no food retention observed. Inadequate bowel preparation was more common in the GLP-1 RA group than the control group among individuals undergoing colonoscopy or combined EGD-colonoscopies (21.3 versus 6.5 percent; odds ratio, 3.9). There were no aspiration events, respiratory distress, or aspiration pneumonia visits.

"Contrary to previous reports, our study identified a clear association between GLP-1 RA use and unsatisfactory bowel preparation, which carries significant risks for missed lesions, patient dissatisfaction, and procedure cancellation, with wasted resources," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2024

Read this next

2021 USPSTF Recommendation Boosted Colorectal Cancer Screening

FRIDAY, Oct. 4, 2024 -- Uptake of colorectal cancer (CRC) screening increased after the 2021 U.S. Preventive Services Task Force (USPSTF) recommendation that all average-risk...

cfDNA Fragmentome, Protein Analyses Detect Ovarian Cancer

FRIDAY, Oct. 4, 2024 -- Integrated cell-free DNA (cfDNA) fragmentome and protein analyses detect ovarian cancers with high performance, according to a study published online Sept...

Subclinical Atherosclerosis Burden Linked to All-Cause Mortality

FRIDAY, Oct. 4, 2024 -- For asymptomatic individuals, subclinical atherosclerosis burden is associated with all-cause mortality, according to a study published in the Oct. 8 issue...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.